Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/1999
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051234A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051233A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326139A1 Antagonists of gonadotropin releasing hormone
10/13/1999EP0949250A1 Process for manufacturing alpha1L-adrenoceptor antagonists
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231604A Medicine treating
10/13/1999CN1231195A Capsule for treating prostate diseases and preparation process
10/13/1999CN1231174A Medicinal compositions for curing cardio-vascular diseases and benign prostatomegaly
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999CN1045597C Alkylenediamine derivatives having heterocyclic group and medicinal composition thereof
10/13/1999CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/12/1999US5965763 Biphenyl compounds
10/12/1999US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999US5965732 Sulfonamide endothelin antagonists
10/12/1999US5965701 Kappa receptor opioid peptides
10/12/1999US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965529 Inhibiting nitric oxide dependent contractility of the uterus
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965175 Feeding a dog a diet of pet food containing fermentable fibers having an organic matter disappearance of 15-60% when fermented by fecal bacteria for 24 hours, the fibers being present in amounts of 1-11%; increased elimination
10/07/1999WO1999050275A2 Macrolide lhrh antagonists
10/07/1999WO1999050272A1 Phosphinic acid derivatives
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999033453A3 R-procyclidine for treating urinary incontinence
10/07/1999CA2325521A1 Macrolide lhrh antagonists
10/06/1999EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/06/1999EP0946174A1 Treatment of urinary incontinence and compositions for use therein
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962497 A 3,4-diphenyl substituted chroman compound
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5961980 Bowman-birk inhibitor compositions and methods for the treatment of genitourinary diseases
10/05/1999CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
09/1999
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999048858A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999WO1999048493A1 Transdermal therapeutic system (tts) containing oxybutynin
09/30/1999WO1999041387A3 Prostate-associated serine protease
09/30/1999WO1999029308A3 Method for combating obesity
09/30/1999CA2325943A1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999CA2323782A1 Methods for prevention and treatment of cancer
09/29/1999EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods
09/29/1999EP0944720A1 Adaptor protein frs2 and related products and methods
09/29/1999EP0944631A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/29/1999EP0944630A1 Xanthines and their therapeutic use
09/29/1999EP0944621A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use
09/29/1999EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944599A1 Triarylethanes useful as pde iv inhibitors
09/29/1999EP0944594A1 Inhibitors of the enzymatic activity of psa
09/29/1999EP0944592A1 Vitamin d3 derivatives
09/29/1999EP0944388A2 Inhibitors of farnesyl-protein transferase
09/29/1999EP0474645B1 Protein complex
09/29/1999CN1230222A PTX-sensitive G proteins, prodn. and use thereof
09/29/1999CN1230220A Therapy for 'alpha'-galactosidase deficiency
09/29/1999CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof
09/29/1999CN1230121A Means for treating prostate hypertrophy and prostate cancer
09/28/1999US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999US5958968 Cardiovascular disorders; kidney dieases
09/28/1999US5958953 Substituted indazole derivatives
09/28/1999US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists
09/28/1999US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
09/28/1999US5958916 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 562